Cytokinetics Announces MYQORZO™ (aficamten) Now Available in the U.S. for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve ...

MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCMSOUTH SAN FRANCISCO, Calif., ...

Cytokinetics, Incorporated: Cytokinetics Announces MYQORZO (aficamten) Now Available in the U.S. for the Treatment of Adults with Symptomatic Obstructive Hypertrophic ...

MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCM SOUTH SAN FRANCISCO, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incor ...

New study reveals widespread liver dysfunction in Down syndrome, suggests link to diet

Researchers at the University of Colorado Anschutz Linda Crnic Institute for Down Syndrome (Crnic Institute) have uncovered ...

ABLi Therapeutics Completes Collaboration Agreement with The Michael J. Fox Foundation to include Risvodetinib in Path to Prevention Platform Trial

ABLi Therapeutics (“ABLi”), a biotechnology company developing therapeutics to address diseases that are associated with activation of Abelson Tyrosine Kinases (c-Abl kinases), announces it has ...
Stockhead on MSN

LTR Pharma doses first patients in SPONTAN Phase II study for ED

The first patients have been dosed in LTR Pharma’s Phase II pharmacokinetic clinical study of SPONTAN, its nasal spray to ...

FDA Approves Compassionate Use of Urcosimod (0.05%) for the Treatment of Neuropathic Corneal Pain

OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the ...
News-Medical.Net on MSN

Alterations in liver metabolism experienced by individuals with Down syndrome

Researchers at the University of Colorado Anschutz Linda Crnic Institute for Down Syndrome (Crnic Institute) have uncovered ...

Are llamas big pharma's secret weapon to find new drugs?

One llama is sprawled on the grass with its neck craned, basking in a patch of sunshine. Another stands on a dirt hill, ears ...
Fierce Biotech

With 200 JPM meetings, Novo Nordisk BD head searches for the next Metsera

What was once a barren field five years ago is now in a “virtuous cycle,” a transformation that Darsow felt firsthand as the ...
Pharmabiz

IntraBio’s Aqneursa receives European Commission’s marketing approval for treatment of Niemann-Pick Type C disease

IntraBio’s Aqneursa receives European Commission’s marketing approval for treatment of Niemann-Pick Type C disease: Austin, Texas Saturday, January 24, 2026, 14:00 Hrs [IST] I ...

Countdown for a Cure Partners with Dr. Taz Bhatia M.D. and hol+ to Advance Mitochondrial Research and Awareness

Dr. Taz Bhatia M.D., a nationally recognized integrative medicine physician, author, and founder of hol+, has partnered with nonprofit Countdown for a Cure (CFAC) to help advance awareness, education, ...

IntraBio Inc.: IntraBio Receives European Commission Approval of AQNEURSA for the Treatment of Niemann-Pick Type C Disease

IntraBio Inc. today announced that the European Commission granted marketing authorization to AQNEURSA(levacetylleucine) for the treatment of neurological manifestations of Niemann-Pick Type C (NPC) ...